• E-ISSN: 2348-1064
  • Follow us

Journal of Nutrition Research
An official journal of IAPEN India association

Article

Nutritional Management in Gastroparesis – An Overview of Guideline Recommendation
  • VIEWS 47
  • PDF 27

Journal of Nutrition Research

DOI: 10.55289/jnutres/v13i1.23.19

Year: 2025, Volume: 13, Issue: 1, Pages: 1-6

Guideline

Nutritional Management in Gastroparesis – An Overview of Guideline Recommendation

Uma Sankari Vijayanand1∗, S S Safeena Beevi2

1Dietician, Department of Dietetics, Jawaharlal Institute of postgraduate medical education and research (JIPMER), Puducherry, India
2Associate Professor, College of Nursing, Aligarh Muslim University, Aligarh, Uttar Pradesh, India

*Corresponding Author
Email: [email protected]

Received Date:27 June 2023, Accepted Date:24 January 2025, Published Date:23 August 2025

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Gastroparesis or slow emptying of the stomach is a debilitating disorder of G.I motility characterised by delayed gastric emptying of especially solid foods in the absence of mechanical obstruction. Gastroparesis (GP) or delayed gastric emptying (GE), is a debilitating disease process that affects an estimated 4% population and more common among diabetic population with evidence of about 30 -40%. Though this condition is increasingly encountered in clinical practice, there is not much evidence-based guidelines pertaining to nutritional management, current dietary recommendations are based on clinical practice. The purpose of dietary management in GP is to reduce the symptoms, maintain nutritional status and to improve the quality of life. This article will give an overview on symptoms, diagnosis, nutritional assessment, and nutritional management in gastroparesis.

Keywords: Delayed gastric emptying, Nutrition, Gastroparesis, Diabetic gastroparesis

References

  1. Camilleri M, Bharucha AE, Farrugia G. Epidemiology, mechanisms, and management of diabetic gastroparesis. Clinical Gastroenterology and Hepatology. 2011;9(1):5–12. Available from: https://doi.org/10.1016/j.cgh.2010.09.022
  2. Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. Clinical guideline: management of gastroparesis. American Journal of Gastroenterology. 2013;108(1):18–37. Available from: https://doi.org/10.1038/ajg.2012.373
  3. Donthireddy KR, Ailawadhi S, Nasser E, Schiff MD, Nwogu CE, Nava HR, et al. Malignant gastroparesis: pathogenesis and management of an underrecognized disorder. Journal of Supportive Oncology. 2007;5(8):355–363. Available from: https://pubmed.ncbi.nlm.nih.gov/17944143/
  4. Reintam A, Parm P, Kitus R, Kern H, Starkopf J. Gastrointestinal symptoms in intensive care patients. Acta Anaesthesiologica Scandinavica. 2009;53(3):318–324. Available from: https://doi.org/10.1111/j.1399-6576.2008.01860.x
  5. Fontana RJ, Barnett JL. Jejunostomy tube placement in refractory diabetic gastroparesis: a retrospective review. American Journal of Gastroenterology. 1996;91(10):2174–2178. Available from: https://pubmed.ncbi.nlm.nih.gov/8855743/
  6. Tack J. Gastric motor disorders. Best Practice & Research Clinical Gastroenterology. 2007;21(4):633–644. Available from: https://doi.org/10.1016/j.bpg.2007.04.001
  7. Tougas G, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: establishment of international control values. American Journal of Gastroenterology. 2000;95(6):1456–1462. Available from: https://doi.org/10.1111/j.1572-0241.2000.02076.x
  8. Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1989;32(3):151–159. Available from: https://doi.org/10.1007/bf00265086
  9. Lee AA, Rao S, Nguyen LA, et al. Validation of diagnostic and per- formance characteristics of the wireless motility capsule in patients with suspected gastroparesis. Clinical Gastroenterology and Hepatology. 2019;17(9):1770–1779. Available from: https://doi.org/10.1016/j.cgh.2018.11.063
  11. Cuoco L, Montalto M, Jorizzo RA, et al. Eradication of small intestinal bacterial overgrowth and orocecal transit in diabetics. HepatoGastroenterology. 2002;49(48):1582–1586. Available from: https://pubmed.ncbi.nlm.nih.gov/12397741/
  13. Taylor JR, Streetman DS, Castle SS. Medication bezoars: A literature review and report of a case. Annals of Pharmacotherapy. 1998;32(9):940–946. Available from: https://doi.org/10.1345/aph.17420
  14. Delpre G, Kadish U, Glanz I. Metoclopramide in the treatment of gastric bezoars. American Journal of Gastroenterology. 1984;79(9):739–740. Available from: https://pubmed.ncbi.nlm.nih.gov/6475910/
  15. Parkman HP, Yates KP, Hasler WL, et al. Dietary intake and nutritional deficiencies in patients with diabetic or idiopathic gastroparesis. Gastroenterology. 2011;141(2):486–498. Available from: https://doi.org/10.1053/j.gastro.2011.04.045
  16. Parkman HP, Hasler WL, Fisher RS. American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis. Gastroenterology. 2004;127(5):1592–1622. Available from: https://doi.org/10.1053/j.gastro.2004.09.055
  17. Pasricha J, Mccallum RW, Farrugia G, Soffer E, Prather C, Hasler W, et al. Gastroparesis: Consensus Guidelines for Treatment. American Motility Society and GDPA. 2005 (manuscript in progress).
  18. Shopbell JM, Hopkins B, Shronts EP. Nutrition screening and assessment. In: MG., ed. The Science and Practice of Nutrition Support: A Case-Based Core Curriculum. (pp. 119) Kendall/Hunt. 2001.
  19. Camilleri M, Chedid V, Ford AC, Haruma K, Horowitz M, Jones KL, et al. Gastroparesis. Nature reviews Disease Primers. 2018;4(1):41. Available from: https://doi.org/10.1038/s41572-018-0038-z
  20. Pawson R, Mehta A. Review article: The diagnosis and treatment of haematinic deficiency in gastrointestinal disease. Alimentary Pharmacology & Therapeutics. 1998;12(8):687–698. Available from: https://doi.org/10.1046/j.1365-2036.1998.00368.x
  22. Lehmann S, Ferrie S, Carey S. Nutrition Management in Patients With Chronic Gastrointestinal Motility Disorders: A Systematic Literature Review. Nutrition in Clinical Practice. 2020;35(2):219–230. Available from: https://dx.doi.org/10.1002/ncp.10273
  23. Arden NK, Cooper C. Assessment of the risk of fracture in patients with gastrointestinal disease. European Journal of Gastroenterology & Hepatology. 2003;15(8):865–868. Available from: https://doi.org/10.1097/00042737-200308000-00005
  24. Camilleri M, Kuo B, Nguyen L, et al. ACG Clinical Guideline: Gastroparesis. American Journal of Gastroenterology. 2022;117(8):1197–1220. Available from: https://doi.org/10.14309/ajg.0000000000001874
  25. Wauters L, Dickman R, Drug V, Mulak A, Serra J, Enck P, et al. United European Gastroenterology (UEG) and European Society for Neurogastroenterology and Motility (ESNM) consensus on functional dyspepsia. United European Gastroenterology Journal. 2021;9(3):307–331. Available from: https://doi.org/10.1002/ueg2.12061
  26. Olausson EA, Störsrud S, Grundin H, Isaksson M, Attvall S, Simrén M. A Small Particle Size Diet Reduces Upper Gastrointestinal Symptoms in Patients With Diabetic Gastroparesis: A Randomized Controlled Trial. American Journal of Gastroenterology. 2014;109(3):375–385. Available from: https://dx.doi.org/10.1038/ajg.2013.453
  27. Feldman M, Friedman LS, Brandt LJ. Sleisenger and Fordtran’s Gastrointestinal and Liver Disease (11). Philadelphia. Elsevier/Saunders. 2020.
  28. Szlachcic A, Brzozowski T. Budowa i czynność żołądka. In: Wielka Interna – Gastroenterologia. (pp. 89-90) Warszawa . Medical Tribune Polska. 2019.
  29. Urbin JLC, Maurer AH. The Stomach. In: Wagner HN, Szabo Z, Buchanan JW., eds. Principles of Nuclear Medicine (2). (pp. 916-918) Philadelphia, PA. WB Saunders. 1995.
  30. Langdon DE. Liquid and chewable iron in post-gastrectomy anaemia. Alimentary Pharmacology & Therapeutics. 1999;13(4):567. Available from: https://doi.org/10.1046/j.1365-2036.1999.0494a.x
  31. Gungabissoon U, Hacquoil K, Bains C, Irizarry M, Dukes G, Williamson R, et al. Prevalence, Risk Factors, Clinical Consequences, and Treatment of Enteral Feed Intolerance During Critical Illness. Journal of Parenteral and Enteral Nutrition. 2015;39(4):441–448. Available from: https://doi.org/10.1177/0148607114526450
  32. Mentec H, Dupont H, Bocchetti M, Cani P, Ponche F, Bleichner G. Upper digestive intolerance during enteral nutrition in critically ill patients: Frequency, risk factors, and complications. Critical Care Medicine. 2001;29(10):1955–1961. Available from: https://doi.org/10.1097/00003246-200110000-00018
  33. Singer P, Blaser AR, Berger MM, Alhazzani W, Calder PC, Casaer MP, et al. ESPEN guideline on clinical nutrition in the intensive care unit. Clinical Nutrition. 2019;38(1):48–79. Available from: https://doi.org/10.1016/j.clnu.2018.08.037

Copyright

© This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Published By India Association for Parenteral and Enteral Nutrition (IAPEN)

  • 23 August 2025

Year: 2025, Volume: 13, Issue: 1


More articles

DON'T MISS OUT!

Subscribe now for latest articles and news.